Dr. Jeffrey I Weitz and Dr. C. Michael Gibson Discuss: ROXI~ Two Mechanistically Distinct Factor XI Antibodies, REGN9933 and REGN7508, for the Prevention of Venous Thromboembolism After Knee Arthroplasty: the ROXI-VTE-I and ROXI-VTE-II trials November 8, 2025 2025 | AHA | Cardiology | Slides | Trial | Video Tags: 2025, AHA, Cardiology, slides, video Weitz, Jeff_AHA 2025 ROXI-I and ROXI-II Presentation_110325_FINAL_updatedDownload Disclosures: TBD Article Navigation Dr. Paul Burton and Dr. C. Michael Gibson Discuss: Effect of Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial Dr. Mary McDermott and Dr. C. Michael Gibson discuss the PERMET trial: Can metformin improve walking performance in nondiabetic patients with peripheral artery disease?
